Clinical Trial Update: Delafloxacin Plasma and Tissue Concentration in Patients With Skin, Soft Tissue, and Bone and Joint Infections.

View source ↗

Summary

A clinical trial update examining delafloxacin plasma and tissue concentrations in patients with soft tissue, mediastinitis, and bone/joint infections.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Mediastinitis
• Osteomyelitis
• Prosthetic Joint Infection
• Septic Arthritis
• Soft Tissue Infections

Drugs mentioned

• Delafloxacin (delafloxacin)

Snippet

Sponsor: IRCCS San Raffaele | Conditions: Soft Tissue Infections, Mediastinitis | Status: NOT_YET_RECRUITING